Vanberra Signal

NetScientific Group

Curated by Signal

Non-invasive glucose monitoring device

Overview

Glucosense Diagnostics is developing a non-invasive device to directly monitor blood glucose levels. The device is based on proprietary photonics technology. It uses nano-engineered silica glass with ions that fluoresce in the infrared region when stimulated by a low power laser. When the glass is in contact with the user’s skin, the reflected fluorescence signal varies based on the concentration of glucose in their blood. According to the company, the process takes less than 30 seconds. The device is under development and not currently available for sale. Glucosense Diagnostics is a portfolio company of NetScientific Group.

Key facts

Founded
2005

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Provider of orthopedic products for rehabilitation

    Life Sciences TechnologyBasingstoke, United Kingdom
  • Provider of nutritional supplemnts to improve women health

    Life Sciences TechnologyLondon, United Kingdom
  • Provider of therapeutics for fertility treatment

    Life Sciences TechnologyHemel Hempstead, United Kingdom

About NetScientific Group

What does NetScientific Group do?

Glucosense Diagnostics is developing a non-invasive device to directly monitor blood glucose levels.

Where is NetScientific Group headquartered?

NetScientific Group is headquartered in London, United Kingdom.

When was NetScientific Group founded?

NetScientific Group was founded in 2005.

Which sector is NetScientific Group in?

NetScientific Group operates in Life Sciences Technology.

Who are NetScientific Group's competitors?

Companies similar to NetScientific Group include Blatchford, Evelyn Health, and LD Collins.